Title of article :
Sensitivity of indocyanine green angiography compared to fluorescein angiography and enhanced depth imaging optical coherence tomography during tapering and fine-tuning of therapy in primary stromal choroiditis: A case series
Author/Authors :
Elahi Sina Retinal and Inflammatory Eye Diseases - Centre for Ophthalmic Specialized Care - Clinic Montchoisi Teaching Centre - Lausanne, Switzerland , Gillmann Kevin Retinal and Inflammatory Eye Diseases - Centre for Ophthalmic Specialized Care - Clinic Montchoisi Teaching Centre - Lausanne, Switzerland , Gasc Amel Retinal and Inflammatory Eye Diseases - Centre for Ophthalmic Specialized Care - Clinic Montchoisi Teaching Centre - Lausanne, Switzerland , Jeannin Bruno Retinal and Inflammatory Eye Diseases - Centre for Ophthalmic Specialized Care - Clinic Montchoisi Teaching Centre - Lausanne, Switzerland , Herbort Jr. Carl P. Retinal and Inflammatory Eye Diseases - Centre for Ophthalmic Specialized Care - Clinic Montchoisi Teaching Centre - Lausanne, Switzerland
Abstract :
To investigate indocyanine green angiography (ICGA), fluorescein angiography (FA), and enhanced depth imaging optical coherence
tomography measured choroidal thickness (EDI-OCT-CT) in the follow-up of inflammatory activity in stromal choroiditis [Vogt-Koyanagi-
Harada disease (VKH) and birdshot retinochoroiditis (BRC)] under treatment in order to monitor tapering of therapy or readjustment of
therapy in case of subclinical disease recurrence.
Methods: Patients with initial onset disease and/or treatment-naive stromal choroiditis (VKH & BRC) at entry, quiet under therapy, and having
had a follow-up of at least four years monitored with dual FA and ICGA and EDI-OCT-CT measurements were analyzed retrospectively. ICGA
and FA scores and EDI-OCT-CT values were correlated with therapy, and significant changes of each modality were correlated with disease
evolution.
Results: Of the 31 VKH and 29 BRC patients seen from 1995 to 2017 in our center, four patients (2 VKH and 2 BRC patients) fulfilled the
inclusion criteria. During tapering, two patients (both VKH) showed no significant ICGA, FA, and EDI-OCT-CT changes (mean follow-up time
5.6 years) and allowed for safe tapering. In the other two (BRC) patients (mean follow-up time 6.25 years), a total of seven significant subclinical
changes were demonstrated by ICGA alone after therapy modifications due to side-effects or during attempted tapering of therapy, while FA and
EDI-OCT-CT remained unchanged.
Conclusions: ICGA was the most sensitive monitoring modality of stromal choroiditis, able to identify subclinical recurrences following change
of therapy and inversely treatment responses after readjusted therapy, events otherwise missed by FA and EDI-OCT. ICGA proved efficient for
safe therapy tapering or for timely adjustment of therapy in stromal choroiditis when necessary.
Keywords :
VKH , Indocyanine green angiography , Vogt-Koyanagi-Harada disease , Birdshot retinochoroiditis , Treatment , Stromal choroiditis
Journal title :
Journal of Current Ophthalmology